Search research articles
Contact Us
Filters
Showing results (21-30 of 144) with videos related to
Page
of 15
Sort By:
Plos One
|
September 10, 2013
Chronic cadmium exposure stimulates SDF-1 expression in an ERα dependent manner
Esmeralda Ponce, Natalie B Aquino, Maggie C Louie
International Journal of Nanomedicine
|
June 20, 2019
CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties
Lawrence D Mayer, Paul Tardi, Arthur C Louie
The Journal of Experimental Medicine
|
December 1, 1989
Identification and characterization of new murine T cell receptor beta chain variable region (V beta) genes
M C Louie, C A Nelson, D Y Loh
Cancer Letters
|
July 1, 1979
Synergistic effect of diethylstilbestrol on the mutagenicity of 2-acetylaminofluorene and N-hydroxy-acetylaminofluorene in the Salmonella assay system
W T Allaben, S C Louie, E J Lazear
Cancer Treatment Reviews
|
December 1, 1983
Pulmonary toxicity of antitumor agents
F M Muggia, A C Louie, B I Sikic
Pediatric Clinics of North America
|
November 18, 2018
Recent Advances in Technology and Its Applications to Pediatric Emergency Care
Marisa C Louie, Todd P Chang, Robert W Grundmeier
Molecular Cancer Research : MCR
|
March 11, 2010
Estrogen receptor regulates E2F1 expression to mediate tamoxifen resistance
Maggie C Louie, Ashley McClellan, Christina Siewit, et al.
Journal of Biomedical Optics
|
March 9, 2021
Constructing a portable optical polarimetry probe for in-vivo skin cancer detection
Daniel C Louie, Lioudmila Tchvialeva, Sunil Kalia, et al.
Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews
|
September 14, 2012
The role of cadmium and nickel in estrogen receptor signaling and breast cancer: metalloestrogens or not?
Natalie B Aquino, Mary B Sevigny, Jackielyn Sabangan, et al.
Journal of Medical Economics
|
March 20, 2020
Healthcare resource utilization in a phase 3 study of CPX-351 in patients with newly diagnosed high-risk/secondary acute myeloid leukemia
Kathleen F Villa, Robert J Ryan, Michael Chiarella, et al.
Page
of 15
Search research articles
Search
Showing results (21-30 of 144) with videos related to
Sort By:
Page
of 15
Plos One
|
September 10, 2013
Chronic cadmium exposure stimulates SDF-1 expression in an ERα dependent manner
Esmeralda Ponce, Natalie B Aquino, Maggie C Louie
International Journal of Nanomedicine
|
June 20, 2019
CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties
Lawrence D Mayer, Paul Tardi, Arthur C Louie
The Journal of Experimental Medicine
|
December 1, 1989
Identification and characterization of new murine T cell receptor beta chain variable region (V beta) genes
M C Louie, C A Nelson, D Y Loh
Cancer Letters
|
July 1, 1979
Synergistic effect of diethylstilbestrol on the mutagenicity of 2-acetylaminofluorene and N-hydroxy-acetylaminofluorene in the Salmonella assay system
W T Allaben, S C Louie, E J Lazear
Cancer Treatment Reviews
|
December 1, 1983
Pulmonary toxicity of antitumor agents
F M Muggia, A C Louie, B I Sikic
Pediatric Clinics of North America
|
November 18, 2018
Recent Advances in Technology and Its Applications to Pediatric Emergency Care
Marisa C Louie, Todd P Chang, Robert W Grundmeier
Molecular Cancer Research : MCR
|
March 11, 2010
Estrogen receptor regulates E2F1 expression to mediate tamoxifen resistance
Maggie C Louie, Ashley McClellan, Christina Siewit, et al.
Journal of Biomedical Optics
|
March 9, 2021
Constructing a portable optical polarimetry probe for in-vivo skin cancer detection
Daniel C Louie, Lioudmila Tchvialeva, Sunil Kalia, et al.
Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews
|
September 14, 2012
The role of cadmium and nickel in estrogen receptor signaling and breast cancer: metalloestrogens or not?
Natalie B Aquino, Mary B Sevigny, Jackielyn Sabangan, et al.
Journal of Medical Economics
|
March 20, 2020
Healthcare resource utilization in a phase 3 study of CPX-351 in patients with newly diagnosed high-risk/secondary acute myeloid leukemia
Kathleen F Villa, Robert J Ryan, Michael Chiarella, et al.
Page
of 15